6th International Conference on
Wound Care, Tissue Repair and Regenerative Medicine

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement; include BBC, ITV, WSJ, CNN, and many more. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. He has commercialised a novel functionalised graphene oxide for medical and other industrial applications. He also commercialised new biodegradable nanocomposite materials for medical and other industrial applications. He is a British citizen and completed his school in the UK (concord college) and his scientific training at London University.

Regenerative Medicine, Tissue bioengineering, Nanotechnology

Dr.Omid Panahi , Graduated from Centro Escolar University on 2013 in field of Doctor of Dental Mediciene( DMD), and MSc Oral and maxillofacial surgery at yeditepe university, Istanbul, turkey. He has published 8 books and more than 50 papers in reputed journals and has been serving as an editorial board member of isi journals.

Regenerative dentistry, Tissue bioengineering, Oral surgery.

Dr. Prakash Kondekar has completed MD (Homoeo) in 1964, BSc (Hons) LLB Doctor of Naturopathy, 1992, Ayurved Ratna FRSH (London) Bowtech (UK). He has been Hon Director-Indian Institute of Naturopathy since 1996. He has published 30 papers-in-medical journals. Visiting Faculty, Mumbai University. Since 2011, invited by AICR Washington DC 2003. INDIA-VIETNAM INVESTMENT ENGAGEMENT Ho-Chi-Minh City-2013, GFSI Barcelona, Spain. St Cloud University Minneapolis-Food Microbiology, 2013, Vienna Energy Forum 2015, Indian-Embassy-ROME 2016. Invited by National University of Natural Medicines-Portland, Bastyr University-Kenmore, AM Commerce, and North Texas, University, 2018. Purdue University in 2019. Conducted 450 Health Management Programmes India and 20+ in UK, USA, Germany, Mauritius, Vietnam, UAE, Austria, Abu Dhabi, Spain, Singapore.

Food, Medicine

Peter A.Everts has been pioneering in the science and clinical applications of platelet-rich plasma (PRP) technology since 1984 and has been leading research teams in regenerative medicine in using biological therapies. Dr. Everts received his PhD in Medicine from the University of Utrecht in the Netherlands in 2007 on the subject of PRP. At present, he has published and authored more than 50 articles, or book chapters. He has been board member, and chairman of several health care organizations and was member of the sport medicine steering group at the International Olympic Committee. At present he is the Executive Director of Gulf Coast Biologics, a scientific-educational-research-training institute, and Chief Scientific Officer of EmCyte Corporation

Regenerative Medicine, Wound Care and Stem cell therapy